{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:50:32Z","timestamp":1789426232392,"version":"build-2803163510"},"reference-count":123,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.beem.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T14:21:45Z","timestamp":1538144505000},"page":"861-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism"],"prefix":"10.1016","volume":"32","author":[{"given":"Eller-Vainicher","family":"Cristina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falchetti","family":"Alberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.09.010_bib1","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.beem.2018.09.010_bib2","first-page":"e285","article-title":"Sporadic primary hyperparathyroidism","volume":"147","author":"Blanchard","year":"2010","journal-title":"J\u00a0Visc Surg"},{"key":"10.1016\/j.beem.2018.09.010_bib3","series-title":"\u201cThe parathyroids: basic and clinical concepts.\u201d John P. Bilezikian Robert Marcus Michael Levine Claudio Marcocci Shonni J Silverberg John Potts","year":"2014"},{"key":"10.1016\/j.beem.2018.09.010_bib4","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical practice. Primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.09.010_bib5","doi-asserted-by":"crossref","first-page":"251410","DOI":"10.1155\/2011\/251410","article-title":"Primary hyperparathyroidism: an overview","volume":"2011","author":"Mackenzie-Feder","year":"2011","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.beem.2018.09.010_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.2009.02105.x","article-title":"DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes","volume":"266","author":"Falchetti","year":"2009","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.beem.2018.09.010_bib8","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1464-410X.2005.05731.x","article-title":"Familial multiple endocrine neoplasia type I: the urologist is first on the scene","volume":"96","author":"Christopoulos","year":"2005","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.beem.2018.09.010_bib9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"issue":"11","key":"10.1016\/j.beem.2018.09.010_bib10","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/jbmr.125","article-title":"Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"25","author":"Louren\u00e7o","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.09.010_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jocd.2012.11.008","article-title":"Nontraditional manifestations of primary hyperparathyroidism","volume":"16","author":"Walker","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.beem.2018.09.010_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/0004-2730000003381","article-title":"Bone disease in primary hyperparathyroidism","volume":"58","author":"Bandeira","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.09.010_bib13","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2012-4255","article-title":"Trabecular bone score (TBS) - a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism","volume":"98","author":"Silva","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jocd.2012.11.013","article-title":"Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk","volume":"16","author":"Lewiecki","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.beem.2018.09.010_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1759720X12441869","article-title":"Bone disease in primary hyperparathyrodism","volume":"4","author":"Marcocci","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.beem.2018.09.010_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jc.2013-3115","article-title":"What is the best way of assessing neurocognitive dysfunction in patients with primary hyperparathyroidism?","volume":"99","author":"Grant","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11914-008-0014-8","article-title":"Parathyroid hormone and the cardiovascular system","volume":"6","author":"Fitzpatrick","year":"2008","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.beem.2018.09.010_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2014.12.067","article-title":"Mortality associated with primary hyperparathyroidism","volume":"74C","author":"Clifton-Bligh","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.09.010_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2018.09.010_bib20","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2014-4432","article-title":"Is normocalcemic primary hyperparathyroidism harmful or harmless?","volume":"100","author":"Chen","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/jc.2013-3523","article-title":"Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism","volume":"99","author":"Walker","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1055\/s-0043-120670","article-title":"Familial hyperparathyroidism \u2013 disorders of growth and secretion in hormone-secretory tissue","volume":"49","author":"Marx","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2018.09.010_bib23","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Udelsman","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpendmet0265","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism","volume":"2","author":"Silverberg","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib25","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib26","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jocd.2012.11.003","article-title":"Hereditary hyperparathyroidism syndromes","volume":"16","author":"Giusti","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"issue":"10","key":"10.1016\/j.beem.2018.09.010_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jclinpath-2015-203186","article-title":"Clinicopathological correlates of hyperparathyroidism","volume":"68","author":"Duan","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.beem.2018.09.010_bib29","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7230.1","article-title":"Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old","volume":"6","author":"Falchetti","year":"2017","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.beem.2018.09.010_bib30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jpedsurg.2013.11.059","article-title":"Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism","volume":"49","author":"Romero Arenas","year":"2014","journal-title":"J\u00a0Pediatr Surg"},{"issue":"2","key":"10.1016\/j.beem.2018.09.010_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12020-017-1322-5","article-title":"MEN1 in children and adolescents: data from patients of a regional referral center for hereditary endocrine tumors","volume":"59","author":"Vannucci","year":"2018","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2018.09.010_bib32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'\u00e9tude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2018.09.010_bib33","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-018-0512-7","article-title":"Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review","author":"Di Meo","year":"2018","journal-title":"Clin Exp Med"},{"issue":"4","key":"10.1016\/j.beem.2018.09.010_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.14310\/horm.2002.1325","article-title":"Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature","volume":"10","author":"del Pozo","year":"2011","journal-title":"Hormones (Athens)"},{"issue":"4","key":"10.1016\/j.beem.2018.09.010_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcu.22090","article-title":"Intrathyroidal parathyroid carcinoma mimicking a thyroid nodule in a MEN type 1 patient","volume":"42","author":"Lee","year":"2014","journal-title":"J\u00a0Clin Ultrasound"},{"issue":"9","key":"10.1016\/j.beem.2018.09.010_bib37","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1245\/s10434-016-5248-6","article-title":"Differentiating atypical parathyroid neoplasm from parathyroid cancer","volume":"23","author":"Christakis","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.beem.2018.09.010_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cen.12714","article-title":"Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 - case report and review of the literature","volume":"84","author":"Singh Ospina","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2018.09.010_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6061\/clinics\/2012(Sup01)17","article-title":"Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1","volume":"67","author":"Louren\u00e7o","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"10.1016\/j.beem.2018.09.010_bib40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archinte.1985.00360050111019","article-title":"Gastric secretion and hormonal interactions in multiple endocrine neoplasia type I","volume":"145","author":"Gogel","year":"1985","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.beem.2018.09.010_bib41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"American thyroid association guidelines task force on medullary thyroid carcinoma. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0889-8529(18)30121-X","article-title":"Multiple endocrine neoplasia type 2. Clinical features and screening","volume":"23","author":"Raue","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.beem.2018.09.010_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"American Thyroid Association Guidelines Task Force","year":"2009","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.beem.2018.09.010_bib44","first-page":"487","article-title":"Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'Etude des Tumeurs \u00e0 Calcitonine","volume":"83","author":"Schuffenecker","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2018.09.010_bib45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s002689900123","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs \u00e1 Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons","volume":"20","author":"Kraimps","year":"1996","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.beem.2018.09.010_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1530\/eje.0.1390410","article-title":"Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma","volume":"139","author":"Karga","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14310\/horm.2002.1218","article-title":"Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management","volume":"8","author":"Raue","year":"2009","journal-title":"Hormones (Athens)"},{"issue":"3","key":"10.1016\/j.beem.2018.09.010_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-14-0818","article-title":"RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation","volume":"172","author":"Vald\u00e9s","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2018.09.010_bib49","doi-asserted-by":"crossref","first-page":"E336","DOI":"10.1210\/jc.2012-3192","article-title":"Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening","volume":"98","author":"Machens","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.09.010_bib50","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1210\/jc.2013-2622","article-title":"Update: the status of clinical trials with kinase inhibitors in thyroid cancer","volume":"99","author":"Wells","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2018.09.010_bib51","first-page":"1031","article-title":"Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2","volume":"114","author":"O'Riordain","year":"1993","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.beem.2018.09.010_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 2A","volume":"238","author":"Raue","year":"1995","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.beem.2018.09.010_bib53","doi-asserted-by":"crossref","first-page":"T15","DOI":"10.1530\/ERC-17-0266","article-title":"Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms","volume":"25","author":"Guerin","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.beem.2018.09.010_bib54","first-page":"781","article-title":"Multiple endocrine neoplasia syndromes associated with mutation of p27","volume":"36","author":"Lee","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.beem.2018.09.010_bib55","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2018.09.010_bib56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MPH.0000000000000443","article-title":"Parathyroid cancer in the pediatric patient","volume":"38","author":"Davidson","year":"2016","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"9","key":"10.1016\/j.beem.2018.09.010_bib58","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1515\/jpem-2016-0109","article-title":"A\u00a0germline mutation of HRPT2\/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature","volume":"29","author":"Serrano-Gonzalez","year":"2016","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib59","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2005-1239","article-title":"Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance","volume":"91","author":"Guarnieri","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-107-1-54","article-title":"Familial cystic parathyroid adenomatosis","volume":"107","author":"Mallette","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.09.010_bib61","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.beem.2018.09.010_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: clinical and genetic characteristics of thirty-six kindreds","volume":"81","author":"Simonds","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beem.2018.09.010_bib63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2003-030675","article-title":"Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome","volume":"89","author":"Simonds","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","article-title":"Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications","volume":"41","author":"Warner","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.beem.2018.09.010_bib65","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1136\/jmg.2003.012369","article-title":"Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP)","volume":"41","author":"Villablanca","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.beem.2018.09.010_bib66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","article-title":"Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism","volume":"3","author":"Starker","year":"2012","journal-title":"Horm Cancer"},{"issue":"18","key":"10.1016\/j.beem.2018.09.010_bib67","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2018.09.010_bib68","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2265.2010.03870.x","article-title":"A\u00a0homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia","volume":"73","author":"Hannan","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2265.2011.04059.x","article-title":"Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism","volume":"75","author":"Frank-Raue","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.beem.2018.09.010_bib70","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.09.010_bib72","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.09.010_bib73","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/js.2017-00043","article-title":"Ethnicity of patients with germline GCM2 activating variants and primary hyperparathyroidism","volume":"1","author":"Guan","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.beem.2018.09.010_bib74","series-title":"Primer on the metabolic bone diseases and mineral metabolism","first-page":"361","article-title":"Familial hyperparathyroidism (including MEN, FHH, and HPTJT)","author":"Arnold","year":"2009"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2018.09.010_bib75","first-page":"S78","article-title":"Parathyroid tumors and related disorders","volume":"24","author":"DeLellis","year":"2011","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.beem.2018.09.010_bib76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4158\/EP11272.RA","article-title":"Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications","volume":"18","author":"Eldeiry","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2018.09.010_bib77","first-page":"220","article-title":"Familial hypocalciuric hypercalcemia and calcium sensing receptor","volume":"53","author":"Mrgan","year":"2014","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.beem.2018.09.010_bib78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000345675","article-title":"Genetic defects associated with familial and sporadic hyperparathyroidism","volume":"41","author":"Hendy","year":"2013","journal-title":"Front Horm Res"},{"issue":"12","key":"10.1016\/j.beem.2018.09.010_bib79","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/dds105","article-title":"Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites","volume":"21","author":"Hannan","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2018.09.010_bib80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0046-8177(81)80123-2","article-title":"The parathyroid glands in familial hypocalciuric hypercalcemia","volume":"12","author":"Thorgeirsson","year":"1981","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beem.2018.09.010_bib81","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0002-9343(84)90852-0","article-title":"Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia)","volume":"76","author":"Law","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.09.010_bib82","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1210\/jc.2014-2113","article-title":"Uncoupling of secretion from growth in some hormone secretory tissues","volume":"99","author":"Marx","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib83","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2013.09.005","article-title":"Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors","volume":"386","author":"Costa-Guda","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2018.09.010_bib84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3476(87)80083-5","article-title":"Self-limited neonatal hyperparathyroidism in familial hypocalciuric hypercalcemia","volume":"111","author":"Page","year":"1987","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2018.09.010_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.83.1.53","article-title":"Neonatal hyperparathyroidism: the natural course in the absence of surgical intervention","volume":"83","author":"Harris","year":"1989","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2018.09.010_bib86","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005792-198111000-00002","article-title":"The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds","volume":"60","author":"Marx","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beem.2018.09.010_bib87","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-102-4-511","article-title":"Familial benign hypercalcemia (hypocalciuric hypercalcemia): clinical and pathogenetic studies in 21 families","volume":"102","author":"Law","year":"1985","journal-title":"Ann Int Med"},{"key":"10.1016\/j.beem.2018.09.010_bib88","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MED.0b013e32834c3c7c","article-title":"Familial hypocalciuric hypercalcemia: a review","volume":"18","author":"Christensen","year":"2011","journal-title":"Curr Opinion Endocrinol Diab Obes"},{"key":"10.1016\/j.beem.2018.09.010_bib89","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib90","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1002\/cncr.28891","article-title":"Surgery for primary hyperparathyroidism","volume":"120","author":"Callender","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2018.09.010_bib91","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jocd.2012.11.007","article-title":"Surgery in primary hyperparathyroidism: extensive personal experience","volume":"16","author":"Van Udelsman","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.beem.2018.09.010_bib92","series-title":"Atlas of tumor pathology. 3rd series, fascicle 6","article-title":"Tumors of the parathyroid gland","author":"De Lellis","year":"1993"},{"key":"10.1016\/j.beem.2018.09.010_bib93","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","article-title":"Primary hyperparathyroidism: a current perspective","volume":"132","author":"De Lellis","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.beem.2018.09.010_bib94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ando.2015.03.003","article-title":"Parathyroid carcinoma: challenges in diagnosis and treatment","volume":"76","author":"Betea","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.beem.2018.09.010_bib95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ando.2015.03.016","article-title":"Parathyroid carcinoma: diagnostic criteria, classification, evaluation","volume":"76","author":"Do Cao","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.beem.2018.09.010_bib96","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrendo.2012.102","article-title":"Diagnosis and management of parathyroid cancer","volume":"8","author":"Schulte","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2018.09.010_bib97","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hed.23656","article-title":"Molecular profiling in primary hyperparathyroidism","volume":"37","author":"Segiet","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.beem.2018.09.010_bib98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hed.22908","article-title":"Parathyroid cancer: outcome analysis of 16 patients treated at the Princess Margaret Hospital","volume":"35","author":"Erovic","year":"2013","journal-title":"Head Neck"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2018.09.010_bib99","first-page":"E2159","article-title":"Detection rate of (99m) Tc-MIBI single photon emission computed tomography (SPECT)\/CT in preoperative planning for patients with primary hyperparathyroidism: a meta-analysis","volume":"38","author":"Treglia","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.beem.2018.09.010_bib100","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2012-3168","article-title":"Clinical review: parathyroid localization and implications for clinical management","volume":"98","author":"Kunstman","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib101","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-14-0964","article-title":"Preoperative imaging for focused parathyroidectomy: making a good strategy even better","volume":"172","author":"Guerin","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.09.010_bib102","series-title":"The pathophysiologic basis of nuclear medicine","first-page":"281","article-title":"Parathyroid gland","author":"Elgazzar","year":"2015"},{"key":"10.1016\/j.beem.2018.09.010_bib103","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1210\/jc.2014-2821","article-title":"Is 18F-fluorocholine-positron emission tomography\/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?","volume":"99","author":"Michaud","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib104","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2967\/jnumed.115.156018","article-title":"The role of radionuclide imaging in the surgical management of primary hyperparathyroidism","volume":"56","author":"Hindi\u00e9","year":"2015","journal-title":"J\u00a0Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.beem.2018.09.010_bib105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNM.0000000000000262","article-title":"Parathyroid adenoma localization with 99mTcsestamibi SPECT\/CT: a meta-analysis","volume":"36","author":"Wong","year":"2015","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.beem.2018.09.010_bib106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00423-009-0545-1","article-title":"CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism","volume":"395","author":"Wimmer","year":"2010","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.beem.2018.09.010_bib107","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsurg.2008.02.003","article-title":"Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A","volume":"65","author":"Philip","year":"2008","journal-title":"J\u00a0Surg Educ"},{"key":"10.1016\/j.beem.2018.09.010_bib108","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archsurg.135.7.844","article-title":"Preoperative sestamibi scanning and surgical findings at bilateral, unilateral, or minimal reoperation for recurrent hyperparathyroidism after subtotal parathyroidectomy in patients with multiple endocrine neoplasia type 1","volume":"135","author":"Shepherd","year":"2000","journal-title":"Arch Surg"},{"key":"10.1016\/j.beem.2018.09.010_bib109","first-page":"4007","article-title":"Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MAJ.0000000000000441","article-title":"Skeletal lesions in primary hyperparathyroidism","volume":"349","author":"Yang","year":"2015","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","article-title":"Parathyroid surgery in familial hyperparathyroid disorders","volume":"257","author":"Carling","year":"2005","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jso.22040","article-title":"Controversies in parathyroid surgery: the quest for a \u201cmini\u201d unilateral parathyroid operation seems to have gone too far","volume":"105","author":"Norman","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2018.09.010_bib113","doi-asserted-by":"crossref","first-page":"141","DOI":"10.6061\/clinics\/2012(Sup01)23","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?","volume":"67","author":"Giusti","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"10.1016\/j.beem.2018.09.010_bib114","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-015-0696-5","article-title":"Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1)","volume":"52","author":"Giusti","year":"2016","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2018.09.010_bib115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncpendmet0816","article-title":"A\u00a0patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet","volume":"4","author":"Falchetti","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.010_bib116","doi-asserted-by":"crossref","first-page":"906163","DOI":"10.1155\/2010\/906163","article-title":"Clinical use of cinacalcet in MEN1 hyperparathyroidism","volume":"2010","author":"Moyes","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2018.09.010_bib117","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1210\/jc.2016-2481","article-title":"Thiazide treatment in primary hyperparathyroidism-A new indication for an old medication?","volume":"102","author":"Tsvetov","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.09.010_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","article-title":"Primary hyperparathyroidism and the skeleton","volume":"69","author":"Mosekilde","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.beem.2018.09.010_bib119","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/M15-1232","article-title":"The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study","volume":"164","author":"Yeh","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.beem.2018.09.010_bib120","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jgs.15250","article-title":"Protective effect of Denosumab on bone in older women with primary hyperparathyroidism","volume":"66","author":"Eller-Vainicher","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.beem.2018.09.010_bib121","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/cgt.2010.39","article-title":"Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients","volume":"17","author":"Luzi","year":"2010","journal-title":"Cancer Gene Ther"},{"issue":"Suppl. 3","key":"10.1016\/j.beem.2018.09.010_bib122","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4158\/EP11062.RA","article-title":"Are microRNAs involved in the endocrine-specific pattern of tumorigenesis in multiple endocrine neoplasia type 1?","volume":"17","author":"Luzi","year":"2011","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.beem.2018.09.010_bib123","doi-asserted-by":"crossref","first-page":"562","DOI":"10.18632\/oncoscience.79","article-title":"Menin-mediated regulation of miRNA biogenesis uncovers the IRS2 pathway as a target for regulating pancreatic beta cells","volume":"1","author":"Gurung","year":"2014","journal-title":"Oncoscience"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:53:56Z","timestamp":1761497636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18301106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1521690X18301106"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.010","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}